Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	May 31, 2012	May 26, 2011	May 27, 2010
Operating activities
Net earnings	$ 22,734	$ 13,558	$ 16,115
Adjustments to reconcile net earnings to net cash provided by operating activities:
Losses (earnings) on loans to and investments in joint ventures	200	(545)	337
Distributions from joint ventures	254
Loss on disposition of property, equipment and other assets	759	750	428
Loss (gain) on sale of condominium units		752	(403)
Gain on available for sale securities	(676)
Impairment charge			2,575
Amortization of loss on swap agreement	113	113	113
Amortization of favorable lease right	334	334	334
Depreciation and amortization	34,525	33,523	32,312
Stock compensation expense	2,010	1,795	1,607
Deferred income taxes	1,150	5,093	7,812
Deferred compensation and other	1,610	(1,404)	634
Contribution of the Company's stock to savings and profit-sharing plan	738	755	748
Changes in operating assets and liabilities:
Accounts and notes receivable	(185)	2,242	(453)
Other current assets	3,023	(3,387)	466
Accounts payable	(2,887)	871	(2,217)
Income taxes	(308)	4,257	(7,611)
Taxes other than income taxes	870	(349)	(426)
Accrued compensation	6,508	552	373
Other accrued liabilities	(1,744)	2,592	(4)
Total adjustments	46,294	47,944	36,625
Net cash provided by operating activities	69,028	61,502	52,740
Investing activities
Capital expenditures and purchase of theatre	(38,017)	(25,186)	(25,082)
Proceeds from disposals of property, equipment and other assets	4,187	34	766
Proceeds from sale of available for sale securities	785
Increase in restricted cash	(1,072)	(5,310)
Increase in condominium units and other assets	(1,775)	(1,366)	(893)
Premiums returned from split dollar life insurance policies			3,820
Capital contribution in joint venture		(906)
Cash advanced to joint ventures	(55)	(129)
Net cash used in investing activities	(35,947)	(32,863)	(21,389)
Debt transactions:
Proceeds from issuance of notes payable and long-term debt	117,000	52,000	77,895
Principal payments on notes payable and long-term debt	(128,029)	(73,441)	(96,835)
Equity transactions:
Treasury stock transactions, except for stock options	(11,189)	(3,988)	(532)
Exercise of stock options	1,284	1,048	340
Dividends paid	(9,707)	(9,810)	(9,883)
Net cash used in financing activities	(30,641)	(34,191)	(29,015)
Net increase (decrease) in cash and cash equivalents	2,440	(5,552)	2,336
Cash and cash equivalents at beginning of year	3,580	9,132	6,796
Cash and cash equivalents at end of year	$ 6,020	$ 3,580	$ 9,132